On drug marketing focus will shift to pharmacies.docVIP

 PAGE \* MERGEFORMAT 11 On drug marketing focus will shift to pharmacies Not long ago, the State Food and Drug Administration announced a newly revised lt;lt;package insert and labeling regulations, ‘and issued lt;lt;name of the drug on to further standardize the management of the notificationgt;gt; strict control’ more than one drug ‘phenomenon there The industry believes that this will lead to drug marketing focus to shift from the hospital pharmacy, the pharmacy will further enhance the status of the terminal. Today’s pharmaceutical retail market in China 20 years ago is very similar to the U.S. market, and the current high level of intensive U.S. drugstore chain, several large pharmaceutical chain enterprises accounted for almost entirely American pharmaceutical retail market, the largest pharmaceutical retail chain Walgreen2005 annual sales of $ 37 billion. Because of the strong control of the consumer end, and the scale is large enough, these companies with upstream suppliers in procurement negotiations, has the absolute initiative. If such companies as HyperTerminal, then 20 years later, even in the shorter time, China’s pharmaceutical retail industry will not have such a super end it? Area without the king what is HyperTerminal ‘China is a vast geographical differences are significant, in this particular market, if they can hold about 10% market share, more than 2000 stores the number of operating areas covering more than 10 provinces, with annual sales of 2.5 billion yuan or so, the should be regarded as a super terminal. ‘Sinopharm Medicine Holding Co., Ltd. Vice President Lu Jun, the domestic business is still far from done,’ comprehensive development ‘- Nepstar far ahead in the number of directly operated stores, but the financial statements but not ‘beautiful.’ together with its point-spread layout, business advantages scattered in various regions have not yet become a ‘strong end.’ Appears in Lu Jun, China’s pharmaceutical re